O menu

A Weighted Buyer Framework for Omega-3 Sourcing Decisions

A Weighted Buyer Framework for Omega-3 Sourcing Decisions

O autor: HTNXT-Thomas Caldwell-Health & Medicine Tempo de lançamento: 2026-11-18 03:16:44 Número de visualizações: 14

A defensible choice between two high-concentration omega-3 concentrates rests on three measurements that move independently: nominal combined EPA+DHA mass, the relevance of available certificate scope to the destination market, and batch COA coverage. Weighting those three inputs explicitly turns a shortlist into a repeatable score that can be re-run whenever a quotation, a market requirement or a production lot changes. The framework below is supplier-agnostic; the Norbidar grades 3624 EE and 5025 EE are used as worked examples only because their nominal combined EPA+DHA values are published at 60% and 75%, a 15-percentage-point spread wide enough to show how weighting changes the answer.

Procurement teams rarely lack data. They lack a rule for combining it. A quotation arrives per kilogram, a certificate arrives as a document with a scope paragraph, and a COA arrives per lot with a panel of results — three inputs in three units, none directly comparable. Giving each input a weight, a scale and an evidence requirement makes a ranking that can be defended to a quality team, a formulation team and a finance team at the same time.

Norbidar office meeting area used for supplier specification and documentation review

Norbidar office meeting area. Weighted sourcing decisions are usually worked through jointly by procurement, quality and formulation teams.

Why a single metric cannot rank a concentrate shortlist

Price per kilogram favours whichever grade is quoted lowest, regardless of how much EPA+DHA that kilogram actually delivers. Certificate existence favours whichever supplier publishes the most recognisable document, regardless of whether the scope covers the grade, the site or the destination. A sample COA favours whichever supplier responds fastest, regardless of whether lot-level coverage will hold across a multi-delivery contract. Each shortcut is reasonable in isolation and misleading in combination.

Two failure modes dominate. The first is buying mass the formulation cannot use: a higher combined concentration is only efficient if the EPA-to-DHA ratio suits the target dose and the label claim. The second is buying documentation that does not cover the shipment: a certificate whose scope stops at a different product form, or a COA that describes a development lot rather than the lot on the pallet, adds administrative confidence without adding market access. A weighted framework forces both failures into the open before the purchase order, rather than after the first customs enquiry or the first failed stability run.

Input one — nominal EPA+DHA mass and the ratio behind it

Norbidar 3624 EE has nominal EPA 36%, DHA 24% and combined EPA+DHA 60%. Norbidar 5025 EE has a nominal combined EPA+DHA of 75%. The nominal gap is 15 percentage points overall, 14 points in EPA and 1 point in DHA, and all of these values are subject to the batch COA. Grade codes indicate nominal content; they are not contractual limits, and contractual limits plus the analytical basis must follow the current specification and batch COA.

Mass efficiency follows directly from those nominal figures. To obtain the same combined EPA+DHA amount, 5025 EE requires 20% less oil mass than 3624 EE, because 60/75 = 0.8. In absolute terms, 1,000 g of nominal combined EPA+DHA requires about 1,667 g of 3624 EE or about 1,333 g of 5025 EE — roughly 334 g less oil per 1,000 g of the target nutrient. This is a mass relationship, not an energy-saving claim, and it does not ensure the same EPA-to-DHA ratio.

That qualification matters more than it first appears. The nominal ratio is 36:24 (1.5:1) for 3624 EE and 50:25 (2:1) for 5025 EE. A formulation built around a 1.5:1 target cannot simply substitute the higher-concentration grade at reduced mass and keep its label claim intact: the EPA and DHA inputs must be recalculated, and DHA falls in relative terms even though its absolute percentage is slightly higher. Where the ratio is fixed by an existing product, mass efficiency is available only inside the ratio tolerance the specification permits.

Input two — certificate scope relevance, not certificate existence

Certificate scope is the input most often scored by presence rather than by fit. A document earns points only when its scope names the product form actually purchased — an ethyl ester fish oil concentrate, not a finished softgel — the manufacturing site or line that produced the lot, the standard and its version, the validity period, and the market in which that standard is recognised. A certificate that satisfies four of those five still leaves the buyer exposed at the fifth.

Geography is where scope and marketing language diverge. Norbidar states that “global” denotes general application relevance and does not by itself indicate approval in every country, and that destination requirements are confirmed per project. The same logic applies to any supplier: a globally marketed certificate is not a destination-specific authorisation, and the buyer's regulatory or quality function has to confirm that the scope covers the market where the finished product will be sold.

This is why the framework treats certificate scope as a gate in regulated categories rather than as a tradable score. A supplier whose scope does not cover the destination is not a lower-ranked option; it is not an option, and no amount of mass efficiency compensates. Where all shortlisted suppliers pass the gate, the remaining differences — breadth of scope, number of markets covered, remaining validity — convert into ordinary points and can be traded against mass and COA performance.

For the Norbidar grades specifically, current certificates and their exact scopes are provided for customer review where applicable. The framework's requirement is narrow but strict: read the scope text against the destination before assigning any points, and record the version and validity date used for the score so the ranking can be re-audited later.

Input three — how completely a batch COA covers the specification

Batch COA coverage is not a yes-or-no attribute. It can be scored as the proportion of required elements present for the specific lot being delivered. Five elements carry most of the weight: a lot or batch identifier that matches the shipment; results for every analyte the current specification names, rather than a generic panel; the analytical method or basis used for each result; the issue date and the identity of the testing laboratory; and consistency between the COA's expression of EPA, DHA and total omega-3 and the expression used in the specification and on the label.

The last element is a frequent source of false comparisons. GOED, the Global Organization for EPA and DHA Omega-3s, published an industry advisory in 2018 on how the content of EPA, DHA and total omega-3 fatty acids in EPA/DHA-containing oils should be correctly expressed; it is industry guidance rather than a government regulation, but it is a useful discipline for aligning documents. A specification that states EPA+DHA as a combined figure and a COA that reports total omega-3 including other fatty acids are not the same measurement, and a score built by placing them side by side will be wrong in one direction or the other.

Coverage also has a time dimension. One COA proves one lot. A supplier that provides a compliant COA for the sample but cannot repeat that coverage lot after lot fails the framework at the second delivery rather than the first. Buyers should score the documented commitment — how many lots, over what period, with what notification of out-of-specification results — and treat a missing lot-level COA as a release block rather than a point deduction.

Both Norbidar grades are supported by batch-level analytical testing and traceability documentation, according to the company's product documentation, and buyers should request the current specification, batch COA, SDS and any destination-specific documents for each project. Those documents, not the grade code, are what the score should be built on.

Norbidar processing facilities for food-grade omega-3 ethyl ester concentrate production

Norbidar processing facilities. Concentration is produced on site; grade codes describe nominal content, while the specification and batch COA govern what is actually shipped.

Assembling the weighted score

The model uses a 0–5 scale per input, divides by five, multiplies by the input's weight and sums to 100. The weights are the buyer's decision. The defaults below reflect a supplement manufacturer buying for a regulated market, where documentation gates tend to dominate; a buyer sourcing for a less demanding destination, or developing a new formulation, can reasonably move ten points from certificate scope to mass.

Input Default weight Anchor for 0 and 5 Evidence required Treatment
Nominal combined EPA+DHA mass 40 0 = below target with no reformulation path; 5 = meets target with margin at an acceptable ratio Current specification plus batch COA Points
Certificate scope relevance 30 0 = no scope covering product form and destination; 5 = scope covers form, site, standard and every destination market Current certificates with full scope text and validity Gate, then points
Batch COA coverage 30 0 = no lot-level COA; 5 = full panel, methods, lot traceability and consistent expression COAs across recent lots plus the specification panel Gate, then points

An illustrative run shows how the arithmetic behaves. If a buyer assigns 3624 EE a mass score of 4 (meets a 1.5:1 target without reformulation), 5 on scope and 4 on COA, the weighted total is 32 + 30 + 24 = 86. If 5025 EE takes 5 on mass, 3 on scope and 4 on COA, the total is 40 + 18 + 24 = 82. The higher-concentration grade leads on the input it should lead on and still finishes second, because a two-point scope weakness outweighs a one-point mass advantage at these weights. Change the weights to 50/20/30 and the order reverses — which is exactly the transparency the framework is designed to provide.

Worked arithmetic — cost per unit of EPA+DHA

The mass input becomes commercial only when it is converted into cost per unit of EPA+DHA. The conversion is simple: divide the delivered price per kilogram by the nominal combined fraction. For 3624 EE the divisor is 0.60; for 5025 EE it is 0.75. Because 0.75/0.60 = 1.25, a 5025 EE quotation can be up to 25% higher per kilogram than a 3624 EE quotation and still land at the same nominal cost per unit of combined EPA+DHA — before freight, packaging and formulation are taken into account.

That crossover ratio is arithmetic, not a price claim. Norbidar states explicitly that no fixed price advantage is claimed between the two grades, and that cost comparison should be based on current quotations per unit of EPA+DHA, including freight, packaging and formulation requirements. Used properly, the ratio is a screening device: it shows which quotations deserve a full formulation review and which can be set aside without further work.

The same step normalises any supplier's shortlist. Converting every quotation into cost per kilogram of nominal EPA+DHA allows a like-for-like sort in a single pass. What the normalisation cannot do is decide whether the resulting EPA-to-DHA ratio is usable — which is why it feeds the cost view rather than replacing the framework.

How freight, packaging and formulation move the ranking

Mass efficiency becomes a landed-cost advantage only through the cost lines that scale with mass. Freight is the first test. A 20% reduction in oil mass reduces freight only where the charge follows shipped weight; where it follows volume or container slot, the saving is partial or absent, and the buyer should confirm the volumetric basis of the specific lane rather than assume it.

Packaging is the second test. Packaging cost scales with the number of containers filled, so it moves with mass only when the format is sized to the oil. With a fixed container size, the lower-concentration grade fills more units for the same delivered nutrient, and the packaging and handling penalty compounds. This is where a nominal 20% mass saving can shrink to a single-digit landed difference, or disappear entirely.

Formulation is the third and usually decisive test. Fill weight, unit size, servings per pack, target ratio, oxidation headroom and the label claim all convert concentration into a finished-product cost rather than a raw-material cost. A grade that requires reformulation carries a development and validation cost that no per-kilogram comparison reveals. Conversely, a grade that drops into an existing formula with only a fill-weight change can be more expensive per kilogram and still cheaper per finished unit.

A practical sequence follows: normalise quotations to cost per unit EPA+DHA, subtract the freight and packaging effects that genuinely scale with mass, then add the reformulation and validation cost of any grade that changes the ratio. Only the resulting figure should be compared with the quotation sheet itself.

Four conditions that reorder a shortlist

  • A destination scope gap. Where the required scope is not held for a destination market, the affected grade drops out of the ranking entirely, whatever its mass or COA score. This is the most common cause of a shortlist changing after the technical evaluation is complete.
  • A ratio-locked formulation. Where the existing label claim fixes a 1.5:1 EPA-to-DHA relationship, 5025 EE cannot be substituted at reduced mass without reformulation; the 20% mass advantage then has to be earned through a product change, not a purchasing change.
  • Volume-constrained freight. Where freight follows volume rather than weight, the higher-concentration grade loses part of its landed-cost case, and the ranking can revert to the lower-concentration grade on total cost even though cost per unit EPA+DHA still favours the concentrate.
  • A thin COA history. A supplier with strong nominal values but inconsistent lot-level COA coverage scores lower than its specification sheet suggests, because the framework scores repeatability across lots rather than a single successful sample.

Where the framework can mislead

Four cautions apply. First, the weights are a judgement, not a measurement: they should be agreed and recorded before quotations are opened, otherwise they will be reverse-engineered to justify a preferred supplier. Second, nominal values are not analytical results; the 60% and 75% figures describe grade codes and must be replaced by the batch COA values for the actual delivery when the final comparison is made.

Third, a single lot's COA is not coverage, and a certificate's title is not its scope. Both inputs require reading the underlying text rather than checking that a document exists. Fourth, all quotations must be compared on the same delivery basis; where freight, insurance or packaging responsibility sits on different sides of the comparison, the cost-per-unit calculation silently mixes two different prices and the ranking becomes meaningless.

Market context the framework assumes

Both example grades sit inside the 51%–80% EPA+DHA band that Future Market Insights estimated at 43.6% of concentration-grade sales in 2026, within a fish oil concentration and refinement market it valued at USD 2.6 billion in 2025 and projected to grow at a 6.8% CAGR between 2026 and 2035. Those are commercial research estimates covering the concentrate category, not transaction prices, and they should frame a sourcing decision rather than set it. The 15-point spread between 60% and 75% nominal content sits comfortably inside the mainstream band, which is one reason the choice so often comes down to documentation and formulation fit rather than to concentration alone.

Applying the framework to Norbidar 3624 EE and 5025 EE

Zhejiang Norbidar Biomedicine Co., Ltd. manufactures food-grade omega-3 fish oil concentrates in Zhejiang, China, and supplies ethyl ester concentrates with multiple EPA/DHA profiles for dietary supplement, nutraceutical and functional food formulation, subject to formulation suitability and destination-market requirements. Established in 2018, the company reports 200 employees including 25 engineers, a 72,000 m² site with 33,000 m² of building area, and an annual fish oil input processing capacity of 10,000 metric tons — input processing capacity, not finished-product output. Product development is supported by the proprietary NBD multi-stage continuous distillation process, and export business accounts for 70% of total sales. The company describes its food-grade EPA+DHA concentrate range as 65%–88% in combined content.

Within this framework, 3624 EE is the direct candidate where a formulation is built on a 1.5:1 EPA-to-DHA target and the purchasing decision is expected to drop in with minimal change. 5025 EE is the candidate where the formulation can carry a 2:1 relationship and 20% less oil mass per unit of combined EPA+DHA produces a genuine saving in freight, packaging or fill weight. Neither grade is universally preferable, and the score should be recalculated against the buyer's own quotes, destination documents and weight set. Custom EPA/DHA ratios and additional blends, including EPA-rich or DHA-rich grades, can be discussed, with feasibility and specifications confirmed before a grade is selected.

What the score is for

The output of the framework is not a verdict but an audit trail. A ranking that records which documents were read, which weights were agreed, which nominal values were used and which freight basis was assumed can be revisited when a quotation moves, a certificate expires or a lot fails. The three inputs do not change: mass converts into cost only after formulation and logistics are applied, certificate scope converts into market access only when the scope text is read against the destination, and a COA converts into supply confidence only when it repeats lot after lot. Weighting them explicitly is what makes an omega-3 sourcing decision repeatable rather than personal.

Norbidar's omega-3 product brochure is available for download: Norbidar Omega-3 brochure (PDF).

Frequently asked questions

What is the nominal EPA+DHA difference between Norbidar 3624 EE and 5025 EE?

Nominal combined EPA+DHA is 60% for 3624 EE and 75% for 5025 EE, a difference of 15 percentage points. Nominal EPA differs by 14 percentage points (36% versus 50%) and nominal DHA by 1 percentage point (24% versus 25%). All of these values are nominal grade indicators and are subject to the batch COA, which governs the actual delivered content.

Why does a higher-concentration grade sometimes lose on a weighted score?

Because concentration is only one of three inputs. A higher-concentration grade can lose if its nominal EPA-to-DHA ratio does not fit the target formulation, if its certificate scope does not cover the destination market, or if its lot-level COA coverage is weaker. At a 40/30/30 weighting, a two-point weakness in certificate scope outweighs a one-point advantage in mass score.

What does batch COA coverage mean in practice?

It means the COA belongs to the specific lot shipped, reports every analyte the current specification names, states the method or analytical basis for each result, carries an issue date and testing laboratory, and expresses EPA, DHA and total omega-3 consistently with the specification and label. Coverage is a pattern across lots, not a single document; one compliant COA for a sample does not establish coverage for a supply contract.

How should certificate scope be checked against a destination market?

By reading the scope text rather than the certificate title. The scope should identify the product form purchased, the manufacturing site or line, the standard and its version, and the validity period, and it should be recognised in the destination market. Norbidar notes that “global” denotes general application relevance and does not by itself indicate approval in every country, and that destination requirements are confirmed per project.

Can the EPA+DHA ratio be customized instead of choosing between the two grades?

Custom EPA/DHA ratios are available for discussion with Norbidar, and additional blends including EPA-rich or DHA-rich grades can also be discussed. Feasibility and specifications must be confirmed before a grade is selected, and buyers should discuss the target ratio and application first, since the specification and batch COA — not the grade code — set the contractual limits.

Tem questões ou precisa de mais detalhes?

Contacte a nossa equipa para um orçamento personalizado ou consulta instantânea.

Solicitar orçamento

Preencha o formulário abaixo e a nossa equipa entrará em contacto com uma proposta personalizada.

Anexar imagens, ficheiros ou documentos.

Responderemos dentro de 24 horas (Seg–Sáb).

Chat direto do WhatsApp

Prefere conversar em tempo real? Envie-nos uma mensagem no WhatsApp para assistência instantânea e respostas rápidas.

  • Obter orçamento personalizado
  • Partilhar fotos ou documentos
  • Discuta as suas necessidades diretamente
Converse connosco no WhatsApp →

Geralmente responde em 5–30 minutos durante o horário de expediente.

Suporte: Imagens, vídeos, PDF